JOHNSON & JOHNSON — Director's Dealing 2022

Oct 26, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2022-10-17

Reporting Person: Forminard Elizabeth (Executive VP, General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3211.0000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Options (Right to Buy)	$115.6700	2027-02-13	Common Stock (11521.0000)		Direct
Employee Stock Options (Right to Buy)	$129.5100	2028-02-11	Common Stock (8921.0000)		Direct
Employee Stock Options (Right to Buy)	$131.9400	2029-02-11	Common Stock (9344.0000)		Direct
Employee Stock Options (Right to Buy)	$151.4100	2030-02-10	Common Stock (13072.0000)		Direct
Employee Stock Options (Right to Buy)	$164.6200	2031-02-08	Common Stock (10756.0000)		Direct
Employee Stock Options (Right to Buy)	$165.8900	2032-02-14	Common Stock (8401.0000)		Direct
Restricted Share Units	$		Common Stock (979.0000)		Direct
Restricted Share Units	$		Common Stock (1022.0000)		Direct
Restricted Share Units	$		Common Stock (851.0000)		Direct

Footnotes

F1: Vested and exercisable on the third anniversary of the date of the grant.

F2: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.